MGI Tech, Eurofins Genomics partner to elevate precision health with revolutionary DNBSEQ-T20×2 sequencer and related technologies
Overview
MGI Tech, a company committed to building core tools and technology to lead life science, announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S (Eurofins Genomics), which has placed a corporate order of the revolutionary DNBSEQ-T20×2 (T20) ultra-high throughput sequencer, along with the genomics data center ZTRON Appliance and a range of MGI’s state-of-the-art laboratory automation products and systems. This marks the first corporate order of the T20 in the Europe region, signalling a significant advancement in precision health initiatives across the continent.
Word from MGI tech
"We are thrilled to work with Eurofins Genomics to leverage T20's ultra-high throughput and remarkable cost-efficiency to empower large population genome projects across the world. With this partnership, we hope to improve accessibility of cost-effective sequencing to researchers globally,"" said Dr. Yong Hou, general manager of MGI Europe and Africa, with enthusiasm.
T20: a Genetic Sequencing Breakthrough
- Powered by MGI’s proprietary DNBSEQä technology, T20 represents a breakthrough in genetic sequencing by significantly reducing sequencing costs to below $100 per genome when running 50,000 WGS per year, garnering global attention.
- Specifically designed to address the most challenging sequencing scenarios, T20 caters to a wide array of high-throughput sequencing needs in scientific and clinical research,including WGS, WGBS, stLFR, single-cell sequencing, Stereo-seq, and more.
- Following its launch in February 2023, T20 has gained widespread adoption among globally leading research institutions and healthcare providers.
Eurofins Genomics
- Eurofins Genomics was founded in 1990 and is part of the Eurofins Scientific Group, a life science company with laboratories in over 50 countries and over 55,000 employees.
- Eurofins Genomics is one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the United States.
MGI: Goal and Commitment
- MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation.
- With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and life course equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries.
